These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 31559008)
1. High oral corticosteroid exposure and overuse of short-acting beta-2-agonists were associated with insufficient prescribing of controller medication: a nationwide electronic prescribing and dispensing database analysis. Sá-Sousa A; Almeida R; Vicente R; Nascimento N; Martins H; Freitas A; Fonseca JA Clin Transl Allergy; 2019; 9():47. PubMed ID: 31559008 [TBL] [Abstract][Full Text] [Related]
2. Asthma Controller Medication Adherence, Risk of Exacerbation, and Use of Rescue Agents Among Texas Medicaid Patients with Persistent Asthma. Makhinova T; Barner JC; Richards KM; Rascati KL J Manag Care Spec Pharm; 2015 Dec; 21(12):1124-32. PubMed ID: 26679962 [TBL] [Abstract][Full Text] [Related]
3. Predictors of excessive short-acting β Kupczyk M; Barg W; Bochenek G; Brożek G; D Browiecki P; Brzostek D; D Browski A; Dobek R; Gawlik R; Kucharczyk A; Kupryś-Lipińska I; Mastalerz-Migas A; Kowalski ML Postepy Dermatol Alergol; 2023 Dec; 40(6):790-797. PubMed ID: 38282873 [TBL] [Abstract][Full Text] [Related]
4. Sex differences in excessive oral corticosteroid exposure in poor adherent adult asthmatics overusing short-acting β-2 agonists. Sposato B; Petrucci E; Lacerenza GL; Micheletto C; Montagnani A; Alessandri M; Cresti A; Serafini A; Lena F; Scala R; Rogliani P; Perrella A; Scalese M Minerva Med; 2023 Oct; 114(5):642-651. PubMed ID: 34269554 [TBL] [Abstract][Full Text] [Related]
5. Asthma beliefs and overuse of short-acting beta-adrenergic receptor agonists among older adults. Ishisaka Y; Ankam J; Feldman J; Busse P; Wisnivesky JP; Federman AD J Asthma; 2024 Sep; ():1-8. PubMed ID: 39258932 [TBL] [Abstract][Full Text] [Related]
6. The Association Between Short-Acting β Price D; Jenkins C; Hancock K; Vella R; Heraud F; Le Cheng P; Murray R; Beekman M; Bosnic-Anticevich S; Botini F; Carter V; Catanzariti A; Doan J; Fletton K; Kichkin A; Le T; Le Lievre C; Lau CM; Novic D; Pakos J; Ranasinghe K; Roussos A; Samuel-King J; Sharma A; Stewart D; Willet B; Bateman E; Adv Ther; 2024 Mar; 41(3):1262-1283. PubMed ID: 38310584 [TBL] [Abstract][Full Text] [Related]
7. Greenhouse Gas Emissions from Respiratory Treatments: Results from the SABA CARBON International Study. Alzaabi A; Bell JP; Montero-Arias F; Price DB; Jackson DJ; Wang HC; Budgen N; Farouk H; Maslova E Adv Ther; 2023 Nov; 40(11):4836-4856. PubMed ID: 37684493 [TBL] [Abstract][Full Text] [Related]
8. Real-time asthma outreach reduces excessive short-acting β2-agonist use: a randomized study. Zeiger RS; Schatz M; Li Q; Solari PG; Zazzali JL; Chen W J Allergy Clin Immunol Pract; 2014; 2(4):445-456, 456.e1-5. PubMed ID: 25017534 [TBL] [Abstract][Full Text] [Related]
9. SABINA + Hong Kong: a territory wide study of prescribing trends and outcomes associated with the use of short-acting β2 agonists in the Chinese population. Fung LW; Yan VK; Kwan C; Kwok WC; Lam DC; McDonald CF; Bloom CI; Wong IC; Chan EW BMC Pulm Med; 2024 May; 24(1):232. PubMed ID: 38745268 [TBL] [Abstract][Full Text] [Related]
10. A retrospective observational study comparing rescue medication use in children on combined versus separate long-acting beta-agonists and corticosteroids. Elkout H; McLay JS; Simpson CR; Helms PJ Arch Dis Child; 2010 Oct; 95(10):817-21. PubMed ID: 20656730 [TBL] [Abstract][Full Text] [Related]
11. Cumulative dispensing of high oral corticosteroid doses for treating asthma in Australia. Hew M; McDonald VM; Bardin PG; Chung LP; Farah CS; Barnard A; Cooper MS; Gibson PG; Upham JW Med J Aust; 2020 Oct; 213(7):316-320. PubMed ID: 32906192 [TBL] [Abstract][Full Text] [Related]
12. Overuse of Oral Corticosteroids in Asthma Is Often Underdiagnosed and Inadequately Addressed. van der Meer AN; de Jong K; Ferns M; Widrich C; Ten Brinke A J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2093-2098. PubMed ID: 35405380 [TBL] [Abstract][Full Text] [Related]
13. Intervention to reduce unnecessary dispensing of short-acting {beta}-agonists in patients with asthma. Wong MD; Manley RT; Stettin G; Chen W; Salmun LM Ann Pharmacother; 2010 Apr; 44(4):623-9. PubMed ID: 20233916 [TBL] [Abstract][Full Text] [Related]
14. Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States. Silver HS; Blanchette CM; Kamble S; Petersen H; Letter M; Meddis D; Gutierrez B J Asthma; 2010 Aug; 47(6):660-6. PubMed ID: 20615167 [TBL] [Abstract][Full Text] [Related]
15. Adequate levels of adherence with controller medication is associated with increased use of rescue medication in asthmatic children. Elkout H; Helms PJ; Simpson CR; McLay JS PLoS One; 2012; 7(6):e39130. PubMed ID: 22761728 [TBL] [Abstract][Full Text] [Related]
16. Overprescription of short-acting β Al Zaabi A; Busaidi N; Al Mutairy S; Yorgancıoğlu A; Aksu K; Al-Jahdali H; Wali S; Elsayed M; Beekman MJ Expert Rev Respir Med; 2022 Jul; 16(7):833-847. PubMed ID: 35848074 [TBL] [Abstract][Full Text] [Related]
18. Real-world evaluation of asthma reliever therapy among continuous users of asthma maintenance medication in Japan: A retrospective cohort study using a claims database. Hozawa S; Kikuchi A; Maeda S Respir Investig; 2023 Mar; 61(2):164-171. PubMed ID: 36689789 [TBL] [Abstract][Full Text] [Related]
19. Seasonal patterns of controller and rescue medication dispensed in underserved children with asthma. Butz AM; Thompson RE; Tsoukleris MG; Donithan M; Hsu VD; Mudd K; Zuckerman IH; Bollinger ME J Asthma; 2008 Nov; 45(9):800-6. PubMed ID: 18972299 [TBL] [Abstract][Full Text] [Related]
20. Over-prescription of short-acting β Chakaya J; Mecha J; Beekman M BMC Prim Care; 2023 Jul; 24(1):141. PubMed ID: 37422638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]